HLA-G and neoplasm: In univariate analysis, advanced stage disease (HR 4.7; 95% CI: 1.16–19.17), IDS (HR 1.8; 95% CI: 1.15–2.91), macroscopic residual tumour (HR 2.6; 95% CI: 1.57–4.43), and lack of expression of HLA-G (HR 1.69; 95% CI: 1.14–2.51) were related to worse survival.